Compounds > ungeremine
Page last updated: 2024-09-04

ungeremine and Experimental Neoplasms

ungeremine has been researched along with Experimental Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, T; Fu, Y; Gong, T; Song, X; Yang, L; Zhang, Z1
Chen, T; Fu, Y; Gong, T; Zhang, Z; Zhao, T1
Shu, RS; Wang, ZW; Xu, B1
Lu, FL; Wang, LJ; Xu, B; Yang, JL; Zhang, SY1
Weng, ZY; Zhang, GR1
Barthelmes, HU; Boege, F; Eisenbrand, G; Fiebig, HH; Marko, D; Niederberger, E; Roth, T; Schulte, K; Tang, WC1

Other Studies

6 other study(ies) available for ungeremine and Experimental Neoplasms

ArticleYear
nRGD modified lycobetaine and octreotide combination delivery system to overcome multiple barriers and enhance anti-glioma efficacy.
    Colloids and surfaces. B, Biointerfaces, 2017, Aug-01, Volume: 156

    Topics: Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents, Hormonal; Cell Proliferation; Central Nervous System Neoplasms; Drug Delivery Systems; Glioma; Indolizines; Male; Mice; Mice, Inbred BALB C; Neoplasms, Experimental; Neovascularization, Pathologic; Octreotide; Oligopeptides; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured

2017
A comparison study between lycobetaine-loaded nanoemulsion and liposome using nRGD as therapeutic adjuvant for lung cancer therapy.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2018, Jan-01, Volume: 111

    Topics: Adjuvants, Pharmaceutic; Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Cell Line, Tumor; Emulsions; Indolizines; Liposomes; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Nanostructures; Neoplasms, Experimental; Oligopeptides; Rats; Rats, Sprague-Dawley; Tissue Distribution

2018
[Nucleolus segregation of tumor cells induced by actinomycin K and lycobetaine (author's transl)].
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1982, Volume: 3, Issue:1

    Topics: Alkaloids; Amaryllidaceae Alkaloids; Animals; Antibiotics, Antineoplastic; Cell Nucleolus; Dactinomycin; Indolizines; Mice; Neoplasms, Experimental

1982
[Effect on animal tumors and toxicity of lycobetaine acetate (author's transl)].
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1981, Volume: 2, Issue:1

    Topics: Alkaloids; Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents, Phytogenic; Dogs; Indolizines; Mice; Neoplasms, Experimental; Structure-Activity Relationship

1981
[Antitumor activity of open ring analogues of ungeremine (AT-1840)--preparation of substituted N-alkyl phenanthridinium bromides by a photochemical reaction].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1984, Volume: 19, Issue:1

    Topics: Alkaloids; Amaryllidaceae Alkaloids; Animals; Antineoplastic Agents; Indolizines; Mice; Neoplasms, Experimental; Phenanthridines; Photochemistry; Structure-Activity Relationship

1984
Lycobetaine acts as a selective topoisomerase II beta poison and inhibits the growth of human tumour cells.
    British journal of cancer, 2001, Nov-16, Volume: 85, Issue:10

    Topics: Alkaloids; Amaryllidaceae Alkaloids; Animals; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Blotting, Western; Cell Cycle; Cell Division; Comet Assay; DNA; DNA Damage; DNA Topoisomerases, Type II; DNA-Binding Proteins; Enzyme Inhibitors; HL-60 Cells; Humans; Indolizines; Mice; Mice, Nude; Neoplasms, Experimental; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays

2001